Auris Medical (EARS) Stock Price, Forecast & Analysis
USA - NASDAQ:EARS -
EARS Key Statistics, Chart & Performance
The current stock price of EARS is 3.045 null. In the past month the price decreased by -13.49%. In the past year, price increased by 204.56%.
EARS Latest News, Press Relases and Analysis
EARS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 44.96 | 935.69B | ||
| JNJ | JOHNSON & JOHNSON | 18.67 | 466.81B | ||
| MRK | MERCK & CO. INC. | 10.32 | 227.17B | ||
| PFE | PFIZER INC | 7.97 | 145.04B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.43 | 99.17B | ||
| ZTS | ZOETIS INC | 18.95 | 53.23B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.48 | 22.72B | ||
| VTRS | VIATRIS INC | 4.81 | 13.06B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.81 | 11.36B | ||
| CORT | CORCEPT THERAPEUTICS INC | 89.78 | 8.33B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 6.97B | ||
| LGND | LIGAND PHARMACEUTICALS | 28.63 | 4.09B |
Related stock screener links
About EARS
Company Profile
Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. The company is headquartered in Zug, Zug and currently employs 9 full-time employees. The company went IPO on 2014-08-06.
Company Info
Auris Medical
Bahnhofstrasse 21
Zug ZUG HM 11 CH
CEO: Thomas Meyer
Employees: 9
Phone: 410612011350.0
Auris Medical / EARS FAQ
What does Auris Medical do?
Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. The company is headquartered in Zug, Zug and currently employs 9 full-time employees. The company went IPO on 2014-08-06.
What is the stock price of Auris Medical today?
The current stock price of EARS is 3.045 null. The price decreased by -1.77% in the last trading session.
Does EARS stock pay dividends?
EARS does not pay a dividend.
What is the ChartMill technical and fundamental rating of EARS stock?
EARS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What sector and industry does Auris Medical belong to?
Auris Medical (EARS) operates in the Health Care sector and the Pharmaceuticals industry.
Can you provide the PE ratio for EARS stock?
Auris Medical (EARS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.45).
Who owns Auris Medical?
You can find the ownership structure of Auris Medical (EARS) on the Ownership tab.
EARS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to EARS. When comparing the yearly performance of all stocks, EARS is one of the better performing stocks in the market, outperforming 94.61% of all stocks.
EARS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to EARS. Both the profitability and financial health of EARS have multiple concerns.
EARS Financial Highlights
Over the last trailing twelve months EARS reported a non-GAAP Earnings per Share(EPS) of -1.45. The EPS increased by 36.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -105.84% | ||
| ROE | N/A | ||
| Debt/Equity | 0.01 |